PMC:7546122 / 1620-1913 JSONTXT

Annnotations TAB JSON ListView MergeView

    LitCovid-PD-FMA-UBERON

    {"project":"LitCovid-PD-FMA-UBERON","denotations":[{"id":"T11","span":{"begin":168,"end":174},"obj":"Body_part"},{"id":"T12","span":{"begin":257,"end":263},"obj":"Body_part"}],"attributes":[{"id":"A11","pred":"fma_id","subj":"T11","obj":"http://purl.org/sig/ont/fma/fma62970"},{"id":"A12","pred":"fma_id","subj":"T12","obj":"http://purl.org/sig/ont/fma/fma62970"}],"text":"After the arrival of West Nile virus (WNV) in the United States, for example, it took several years before the prevalence of WNV nAbs reached approximately 0.5% in the plasma donor community, at which point they became detectable in IVIG lots produced from plasma donated in the United States."}

    LitCovid-PD-CLO

    {"project":"LitCovid-PD-CLO","denotations":[{"id":"T14","span":{"begin":31,"end":36},"obj":"http://purl.obolibrary.org/obo/NCBITaxon_10239"},{"id":"T15","span":{"begin":168,"end":174},"obj":"http://purl.obolibrary.org/obo/UBERON_0001969"},{"id":"T16","span":{"begin":257,"end":263},"obj":"http://purl.obolibrary.org/obo/UBERON_0001969"}],"text":"After the arrival of West Nile virus (WNV) in the United States, for example, it took several years before the prevalence of WNV nAbs reached approximately 0.5% in the plasma donor community, at which point they became detectable in IVIG lots produced from plasma donated in the United States."}

    LitCovid-sentences

    {"project":"LitCovid-sentences","denotations":[{"id":"T12","span":{"begin":0,"end":293},"obj":"Sentence"}],"namespaces":[{"prefix":"_base","uri":"http://pubannotation.org/ontology/tao.owl#"}],"text":"After the arrival of West Nile virus (WNV) in the United States, for example, it took several years before the prevalence of WNV nAbs reached approximately 0.5% in the plasma donor community, at which point they became detectable in IVIG lots produced from plasma donated in the United States."}

    LitCovid-PubTator

    {"project":"LitCovid-PubTator","denotations":[{"id":"34","span":{"begin":21,"end":36},"obj":"Species"},{"id":"35","span":{"begin":38,"end":41},"obj":"Species"},{"id":"36","span":{"begin":125,"end":128},"obj":"Species"}],"attributes":[{"id":"A34","pred":"tao:has_database_id","subj":"34","obj":"Tax:11082"},{"id":"A35","pred":"tao:has_database_id","subj":"35","obj":"Tax:11082"},{"id":"A36","pred":"tao:has_database_id","subj":"36","obj":"Tax:11082"}],"namespaces":[{"prefix":"Tax","uri":"https://www.ncbi.nlm.nih.gov/taxonomy/"},{"prefix":"MESH","uri":"https://id.nlm.nih.gov/mesh/"},{"prefix":"Gene","uri":"https://www.ncbi.nlm.nih.gov/gene/"},{"prefix":"CVCL","uri":"https://web.expasy.org/cellosaurus/CVCL_"}],"text":"After the arrival of West Nile virus (WNV) in the United States, for example, it took several years before the prevalence of WNV nAbs reached approximately 0.5% in the plasma donor community, at which point they became detectable in IVIG lots produced from plasma donated in the United States."}